EXIR PHARMACEUTICAL CO

Company Introduction: Exir Pharmaceutical Co.

Exir Pharmaceutical Co. is a prominent pharmaceutical manufacturing company based in Iran. Established in 1993, it is located in Borujerd, Lorestan Province. The company specializes in the research, development, and production of a wide range of high-quality human pharmaceutical products. Its portfolio includes various therapeutic classes such as antibiotics, cardiovascular drugs, central nervous system medications, and more. Exir is committed to adhering to international Good Manufacturing Practice (GMP) standards, ensuring the efficacy and safety of its products. It plays a significant role in providing essential medicines to the Iranian market and also engages in regional exports. Exir Pharmaceutical Co. operates as a key subsidiary of the Social Security Organization's Investment Company (SHASTA).

Nature of Business: Factory

EXIR Pharmaceutical Co. produces and sells a variety of pharmaceutical products, including:

* Multiple Sclerosis drugs (e.g., CinnoVex)

* Recombinant drugs

* Biosimilar drugs

* Pharmaceutical raw materials

* Finished pharmaceutical products in various therapeutic areas (e.g., cardiovascular, central nervous system, diabetes, etc.)